149 results on '"Long, Heather M."'
Search Results
2. Mutations in SARS-CoV-2 spike protein impair epitope-specific CD4+ T cell recognition
3. Tspan6 stimulates the chemoattractive potential of breast cancer cells for B cells in an EV- and LXR-dependent manner
4. BCL-XL inhibition by BH3-mimetic drugs induces apoptosis in models of Epstein-Barr virus–associated T/NK-cell lymphoma
5. Tracking immunodynamics by identification of S-G2/M-phase T cells in human peripheral blood
6. Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection
7. Bioengineered small extracellular vesicles deliver multiple SARS‐CoV‐2 antigenic fragments and drive a broad immunological response
8. EXTOD-Immune: a randomised controlled trial to investigate whether a remotely monitored, home-based exercise intervention can reduce disease activity in people with type 1 diabetes.
9. Immunology of THymectomy And childhood CArdiac transplant (ITHACA): protocol for a UK-wide prospective observational cohort study to identify immunological risk factors of post-transplant lymphoproliferative disease (PTLD) in thymectomised children
10. Author Correction: Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection
11. Tspan6 stimulates the chemoattractive potential of breast cancer cells for B cells in an EV- and LXR-dependent manner
12. Cellular immune controls over Epstein–Barr virus infection: new lessons from the clinic and the laboratory
13. Isolation of T cell receptors targeting recurrent neoantigens in hematological malignancies
14. Immune defence against EBV and EBV-associated disease
15. A novel latent membrane 2 transcript expressed in Epstein-Barr virus–positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy
16. Cytotoxic CD4+ T-cells specific for EBV capsid antigen BORF1 are maintained in long-term latently infected healthy donors
17. Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
18. CD4+ T-cell clones recognizing human lymphoma-associated antigens: generation by in vitro stimulation with autologous Epstein-Barr virus–transformed B cells
19. Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
20. Mutations in SARS-CoV-2 spike protein impair epitope-specific CD4+T cell recognition
21. Recruitment mechanisms of primary and malignant B cells to the human liver
22. The CD151‐midkine pathway regulates the immune microenvironment in inflammatory breast cancer
23. Non-uniform in vivo Expansion of Epstein-Barr Virus-Specific T-Cells Following Donor Lymphocyte Infusion for Post-transplant Lymphoproliferative Disease
24. The T-cell Response to Epstein-Barr Virus–New Tricks From an Old Dog
25. Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4+ T Cells
26. Complete remission of immunochemotherapy-refractory monomorphic post-transplant lymphoproliferative disorder mediated by endogenous T-cell recovery
27. Targeting EBV-positive B- and T/NK-cell lymphomas
28. Asymptomatic Primary Infection with Epstein-Barr Virus: Observations on Young Adult Cases
29. Early virological and immunological events in asymptomatic Epstein-Barr virus infection in African children
30. Early virological and immunological events in asymptomatic Epstein-Barr virus infection in African children
31. CXCR5+ follicular cytotoxic T cells control viral infection in B cell follicles
32. Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination
33. The Immunology of Epstein-Barr Virus–Induced Disease
34. Cellular immune controls over Epstein-Barr virus infection: new lessons from the clinic and the laboratory
35. MHC II tetramers visualize human CD4+ T cell responses to Epstein–Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response
36. Suppression of Antigen-Specific T Cell Responses by the Kaposi's Sarcoma-Associated Herpesvirus Viral OX2 Protein and Its Cellular Orthologue, CD200
37. Structural definition of HLA class II-presented SARS-CoV-2 epitopes reveals a mechanism to escape pre-existing CD4+T cell immunity
38. Epstein-Barr Virus Evades CD4+ T Cell Responses in Lytic Cycle through BZLF1-mediated Downregulation of CD74 and the Cooperation of vBcl-2
39. Cytotoxic CD4+ T Cell Responses to EBV Contrast with CD8 Responses in Breadth of Lytic Cycle Antigen Choice and in Lytic Cycle Recognition
40. T Cell Detection of a B-Cell Tropic Virus Infection: Newly-Synthesised versus Mature Viral Proteins as Antigen Sources for CD4 and CD8 Epitope Display
41. An Epstein-Barr Virus Anti-Apoptotic Protein Constitutively Expressed in Transformed Cells and Implicated in Burkitt Lymphomagenesis: The Wp/BHRF1 Link
42. A Role for Intercellular Antigen Transfer in the Recognition of EBV-Transformed B Cell Lines by EBV Nuclear Antigen-Specific CD4+ T Cells
43. EBV-Specific CD4+ T Cell Clones Exhibit Vigorous Allogeneic Responses
44. Regression of Epstein-Barr Virus-Induced B-Cell Transformation In Vitro Involves Virus-Specific CD8+T Cells as the Principal Effectors and a Novel CD4+T-Cell Reactivity
45. CXCR5+follicular cytotoxic T cells control viral infection in B cell follicles
46. Epstein-Barr Virus Evades CD4+ T Cell Responses in Lytic Cycle through BZLF1-mediated Downregulation of CD74 and the Cooperation of vBcl-2.
47. Cytotoxic CD4+ T Cell Responses to EBV Contrast with CD8 Responses in Breadth of Lytic Cycle Antigen Choice and in Lytic Cycle Recognition.
48. CD4+T-cell clones recognizing human lymphoma-associated antigens: generation by in vitro stimulation with autologous Epstein-Barr virus–transformed B cells
49. Regression of Epstein-Barr Virus-Induced B-Cell Transformation In Vitro Involves Virus-Specific CD8+ T Cells as the Principal Effectors and a Novel CD4+ T-CeIl Reactivity.
50. Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4+ T Cells.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.